Alex Goldberg

Ceragon Networks Ltd. (NASDAQ:CRNT) and Novavax, Inc. (NASDAQ:NVAX) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/10/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Ceragon Networks Ltd. (NASDAQ:CRNT) and Novavax, Inc. (NASDAQ:NVAX).

Ceragon Networks Ltd. (NASDAQ:CRNT) a company that provides wireless backhaul solutions that enable cellular operators and other wireless service providers to deliver voice and data services worldwide closed up in its previous session (+6.75%) on 1,734,888 shares traded after Coverage was initiated on Ceragon by Needham. Ceragon Networks Ltd. (NASDAQ:CRNT) is currently up (+20%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Ceragon Networks Ltd. (NASDAQ:CRNT)

Novavax, Inc. (NASDAQ:NVAX) a clinical-stage biopharmaceutical company that focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases closed up in its previous session (+0.71%) on 3,749,383 shares traded. Novavax, Inc. (NASDAQ:NVAX) is currently up (+158.33%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Novavax, Inc. (NASDAQ:NVAX)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com